MCID: TRN003
MIFTS: 44

Transverse Colon Cancer malady

Categories: Cancer diseases, Gastrointestinal diseases

Aliases & Classifications for Transverse Colon Cancer

About this section

Aliases & Descriptions for Transverse Colon Cancer:

Name: Transverse Colon Cancer 11 13
Malignant Neoplasm of Transverse Colon 68
 
Malignant Tumor of Transverse Colon 11
Ca Transverse Colon 11

Classifications:



External Ids:

Disease Ontology11 DOID:261
ICD1030 C18.4
ICD9CM32 153.1

Summaries for Transverse Colon Cancer

About this section
MalaCards based summary: Transverse Colon Cancer, also known as malignant neoplasm of transverse colon, is related to herpes zoster and cask-related disorders. An important gene associated with Transverse Colon Cancer is ETFA (Electron Transfer Flavoprotein Alpha Subunit), and among its related pathways are p38MAPK events and Platinum drug resistance. Affiliated tissues include colon, liver and pancreas, and related mouse phenotypes are Synthetic lethal with vaccinia virus (VACV) infection and digestive/alimentary.

Related Diseases for Transverse Colon Cancer

About this section

Diseases related to Transverse Colon Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 103)
idRelated DiseaseScoreTop Affiliating Genes
1herpes zoster10.2COL17A1, DSC2, DSC3
2cask-related disorders10.2MSH6, PMS2
3folinic acid-responsive seizures10.2COL17A1, DSC2, DSC3
4neurocutaneous melanosis, somatic10.2HRAS, MLH1, MSH2
5benign fibrous mesothelioma10.2MLH1, MSH2, MSH6
6pelvic inflammatory disease10.2HRAS, KRAS, KRT20
7allergic contact dermatitis10.2KRAS, KRT20, MLH1
8tabes dorsalis10.2HRAS, KRAS, KRT20
9large cell neuroendocrine carcinoma10.2GNAS, KRAS, KRT20
10congenital symblepharon10.1HRAS, KRAS, MLH1, MSH2
11asperger syndrome10.1MLH1, MSH2, MSH6
12large intestine adenoma10.1MLH1, MSH2, MSH6, PMS2
13neuropathy, distal hereditary motor, type viib10.1MLH1, MSH2, MSH6, PMS2
14cauda equina neoplasm10.1MLH1, MSH2, MSH6, PMS2
15neurofibromatosis-noonan syndrome10.1MLH1, MSH2, MSH6, PMS2
16mismatch repair cancer syndrome10.1MLH1, MSH2, MSH6, PMS2
17fibromatosis, gingival, 110.1MLH1, MSH2, MSH6, PMS2
18autosomal genetic disease10.1MLH1, MSH2, MSH6, PMS2
19t-cell large granular lymphocyte leukemia10.1MLH1, MSH2, MSH6, PMS2
20malignant skin fibrous histiocytoma10.1CEACAM5, HRAS, KRAS
21precursor t-lymphoblastic lymphoma/leukemia10.1CEACAM5, HRAS, KRAS
22breast mucinous cystadenocarcinoma10.1CEACAM5, HRAS, KRAS
23radiculopathy10.0KRT20, KRT7
24adult myxoid chondrosarcoma10.0KRT20, KRT7
25hnrnpa1-related amyotrophic lateral sclerosis10.0KRAS, MLH1, MSH2, MSH6, PMS2
26paroxysmal nocturnal hemoglobinuria10.0CEACAM5, HRAS, KRAS
27hidradenoma10.0KRAS, MLH1, MSH2, MSH6, PMS2
28neuroretinitis10.0KRAS, KRT20, MLH1, MSH2, MSH6
29bronchus mucoepidermoid carcinoma10.0KRT20, KRT7
30seborrheic dermatitis10.0HRAS, MLH1, MSH2, MSH6, PMS2
31postpoliomyelitis syndrome10.0HRAS, KRAS, KRT7
32agenesis and aplasia of uterine body10.0KRAS, KRT20, KRT7
33peritoneal benign neoplasm10.0KRT20, KRT7
34sphenoid sinus squamous cell carcinoma10.0CEACAM5, KRT20, THBD
35skin papilloma10.0HRAS, KRT20, MLH1, MSH2, MSH6
36bilateral hypoactive labyrinth10.0HRAS, KRAS, KRT7
37steroid-induced glaucoma - borderline10.0KRT20, KRT7
38cranial nerve disease10.0CEACAM5, KRT20, THBD
39sagittal sinus thrombosis10.0KRAS, KRT20, KRT7
40non specific chronic endometritis10.0KRT20, KRT7
41cervical serous adenocarcinoma10.0CEACAM5, GNAS, HRAS, KRAS
42monoclonal paraproteinemia10.0CEACAM5, KRAS, KRT20, MLH1
43bardet-biedl syndrome9.9CEACAM5, MLH1, MSH2, MSH6
44dystonia9.9KRT20, KRT7
45mucosal melanoma9.9KRT20, KRT7, MSH6
46alpha chain disease9.9HRAS, KRT20, KRT7
47anal canal paget's disease9.9KRT20, KRT7
48deep angioma9.9CEACAM5, KRT7
49ideomotor apraxia9.9CEACAM5, HRAS, KRAS, MLH1, MSH2
50osteosarcoma arising in bone paget's disease9.9CEACAM5, KRT7

Comorbidity relations with Transverse Colon Cancer via Phenotypic Disease Network (PDN):


Active Peptic Ulcer DiseaseAscending Colon Cancer
Cecal Benign NeoplasmColorectal Cancer
Deficiency AnemiaIntestinal Obstruction
Iron Deficiency AnemiaParalytic Ileus
Protein-Energy MalnutritionRectosigmoid Junction Neoplasm

Graphical network of the top 20 diseases related to Transverse Colon Cancer:



Diseases related to transverse colon cancer

Symptoms & Phenotypes for Transverse Colon Cancer

About this section

GenomeRNAi Phenotypes related to Transverse Colon Cancer according to GeneCards Suite gene sharing:

26
idDescriptionGenomeRNAi Source AccessionScoreTop Affiliating Genes
1GR00362-A8.2DSC3, KRAS, MLH1, MSH6, PIK3C2A, PMS2

MGI Mouse Phenotypes related to Transverse Colon Cancer according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053819.1CYP27A1, EPB41L5, KRAS, MLH1, MSH2, PMS2
2MP:00107718.9DSC3, GNAS, HRAS, KRAS, MLH1, MSH2
3MP:00020068.6GNAS, HCK, HRAS, KRAS, MLH1, MSH2
4MP:00053678.3CYP27A1, GNAS, HRAS, KRAS, KRT7, PIK3C2A
5MP:00053858.1CYP27A1, DSC2, EPB41L5, GNAS, HCK, HRAS
6MP:00107687.1DSC3, EPB41L5, GNAS, HCK, HRAS, KRAS
7MP:00053766.3CYP27A1, EPB41L5, GNAS, HCK, HRAS, KRAS

Drugs & Therapeutics for Transverse Colon Cancer

About this section

Drugs for Transverse Colon Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
FluorouracilapprovedPhase 3185651-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
2AntimetabolitesPhase 312054
3Immunosuppressive AgentsPhase 313086
4Antimetabolites, AntineoplasticPhase 37361
5ColaNutraceuticalPhase 2, Phase 3, Early Phase 11946
6
Propofolapproved, investigational, vet_approvedPhase 210822078-54-84943
Synonyms:
2, 6-Diisopropylphenol
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Bis(Isopropyl)-phenol
2,6-DIISOPROPYLPHENOL
2,6-Diisopropyl phenol
2,6-Diisopropylphenol
2,6-bis(1-methylethyl)-phenol
2,6-di(propan-2-yl)phenol
2078-54-8
28449-97-0
4-06-00-03435 (Beilstein Handbook Reference)
50356-15-5
AB00513968
AC-2038
AC1L1J9Y
AC1Q1OUI
AI3-26295
AM-149
Abbott Brand of Propofol
Alpha Brand of Propofol
Ampofol
Aquafol
Astra Brand of Propofol
AstraZeneca Brand of Propofol
BIDD:GT0436
BPBio1_000950
BPBio1_000969
BRD-K82255054-001-03-5
BRN 1866484
BSPBio_000862
Biomol-NT_000248
Braun Brand of Propofol
C07523
C12H18O
CAS-2078-54-8
CCRIS 9000
CHEBI:44915
CHEMBL526
CID4943
CPD-11437
CPD000059151
Curamed Brand of Propofol
D00549
D015742
D0617
D126608
D126608_ALDRICH
DB00818
DDS-04F
Diisopropylphenol
Dipravan
Diprivan
Diprivan (TN)
Diprivan Injectable emulsion
Disoprivan
Disoprofol
EINECS 218-206-6
EU-0100437
Fresenius Brand of Propofol
Fresenius Kabi Brand of Propofol
Fresofol
HMS1570L04
HMS2089O21
HMS2094E17
 
HSDB 7123
ICI 35,868
ICI 35868
ICI-35,868
ICI-35868
ICI35,868
ICI35868
InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H
Ivofol
Jsp004266
Juste Brand of Propofol
LS-996
Lopac-D126608
Lopac0_000437
MLS001066348
MLS001335999
MLS002454360
MolPort-001-794-517
NCGC00015389-01
NCGC00015389-02
NCGC00015389-04
NCGC00015389-09
NCGC00091538-01
NCGC00091538-02
NCGC00091538-03
NCGC00091538-04
NCGC00091538-05
NCGC00091538-06
NSC 5105
NSC5105
PFL
Parnell Brand of Propofol
Pisa Brand of Propofol
Prestwick0_000931
Prestwick1_000931
Prestwick2_000931
Prestwick3_000931
Propofol
Propofol (JAN/USAN/INN)
Propofol Abbott
Propofol Fresenius
Propofol IDD-D
Propofol MCT
Propofol Rovi
Propofol [USAN:INN:BAN]
Propofol(2,6-Diisopropylphenol)
Propofol-Lipuro
Propofolum
Propofolum [Latin]
Rapinovet
Recofol
Rovi Brand of Propofol
S01-0189
SAM002264610
SMR000059151
SPBio_003031
SPECTRUM1505022
ST50405911
Schering Brand of Propofol
UNII-YI7VU623SF
W505102_ALDRICH
ZD-0859
ZINC00968303
Zeneca Brand of Propofol
ghl.PD_Mitscher_leg0.558
nchembio.552-comp7
propofol
7
Midazolamapproved, illicitPhase 272359467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
 
Dormicum
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
8
Fentanylapproved, illicit, investigational, vet_approvedPhase 2821437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
1-phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl CII
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
Fentanyl-12
Fentanyl-25
 
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-phenethyl-4-piperidyl)propionanilide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenethyl-4-(N-propionylanilino)piperidine
N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
UNII-UF599785JZ
fentanyl
9
BisacodylapprovedPhase 273603-50-9
Synonyms:
Bisacodilo
Bisacodyl
Bisacodyle
 
Bisacodylum
Dulcolax
Phenol, 4,4'-(2-pyridinylmethylene)bis-, diacetate (ester)
Spirolax
10OrangeNutraceuticalPhase 2265
11
Coal tarapproved2028007-45-2
Synonyms:
 
Coal tars
Tar, coal
12
Pancrelipaseapproved97053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
PA
 
Pancreatic alpha-amylase precursor
Pancrelipase (amylase
lipase
protease)
13
Glucosamineapproved, Nutraceutical1913416-24-8439213
Synonyms:
(+)-2-amino-2-deoxy-D-glucopyranose
(2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(2S,5R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
14257-69-3
2-Amino-2-deoxy-D-Glucose
2-Amino-2-deoxy-D-glucopyranose
2-Amino-2-deoxy-D-glucose
2-Amino-2-deoxy-beta-D-glucopyranose
2-Amino-2-deoxyglucose
2-Aminoglucose
2-Deoxy-2-amino-D-glucose
2-Deoxy-2-aminoglucose
2-amino-2-deoxy-D-glucopyranose
2-amino-2-deoxyglucose
2351-15-7
28905-10-4
2B4D44B2-D5AC-4DA4-9BE6-A4AE9574E4A6
3416-24-8
4-04-00-02017 (Beilstein Handbook Reference)
58-87-7
58267-75-7
6490-70-6
880765-44-6
90-77-7
911653-84-4
AC1L2D1C
AC1L96WB
AC1L9B8P
AC1Q4UBH
BRN 1724602
BSPBio_002086
C00329
C08349
CHEBI:28393
CHEBI:47977
CHEMBL234432
CID18897
CID439213
CID441477
CPD0-1193
Chitosamine
Cosamin
D-(+)-Glucosamine
 
D-Glucosamine
D-glucosamine
D04334
DB01296
DivK1c_000261
EINECS 222-311-2
GCS
Glucosamina
Glucosamina [INN-Spanish]
Glucosamine (USAN/INN)
Glucosamine [USAN:INN]
Glucosaminum
Glucosaminum [INN-Latin]
HMS500N03
HSDB 7469
IDI1_000261
InChI=1/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6-/m1/s1
KBio1_000261
KBio2_001311
KBio2_003879
KBio2_006447
KBio3_001306
KBioGR_000970
KBioSS_001311
LS-71671
MolPort-002-507-091
MolPort-003-944-937
NCGC00164421-01
NCGC00178826-01
NINDS_000261
SPBio_000477
STK801823
Spectrum2_000519
Spectrum3_000443
Spectrum4_000565
Spectrum5_000756
Spectrum_000831
Viartril-S
beta-D-Glucosamine
bmse000247
chitosamine
glucosamine
nchembio.189-comp4
nchembio.2007.41-comp7
nchembio.412-comp5
partially N-deacetylated poly-beta-1,6-N-acetyl-D-glucosamine
14Anesthetics9596
15Hypolipidemic Agents2785
16Lipid Regulating Agents2766
17Hypoglycemic Agents5896
18Glucuronyl glucosamine glycan sulfate140
19Fibrinolytic Agents2388
20pancreatin970
21Anticoagulants2623

Interventional clinical trials:

(show all 23)
idNameStatusNCT IDPhase
1SLN in Colon Cancer Using a Multimodal TracerCompletedNCT02850783Phase 2, Phase 3
2Study of Two Techniques of Rectal Reservoir in Low Anterior Resection of RectumCompletedNCT01396928Phase 2, Phase 3
3Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and SafetyActive, not recruitingNCT01465451Phase 3
4Short Term Outcomes of Laparoscopic Intersphincteric Resection for Low Rectal CancerActive, not recruitingNCT01836926Phase 2, Phase 3
5Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.CompletedNCT02104271Phase 2
6Total/Subtotal Colectomy in Ovarian CancerRecruitingNCT02595021Phase 2
7Randomized Controlled Trial Between Laparoscopic and Open Surgery in Transverse and Descending Colon Cancer PatientsActive, not recruitingNCT01861691Phase 2
8Local Ablative Strategies After Endovascular RadioembolizationRecruitingNCT02611661Phase 1
9Linaclotide Acetate in Preventing Colorectal Cancer in Healthy VolunteersActive, not recruitingNCT01950403Phase 1
10Comparison of Limb Size of Transverse Coloplasty PouchUnknown statusNCT01071824
11INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for CancerUnknown statusNCT01679756
12Positioning During ColonoscopyCompletedNCT01254435Early Phase 1
13Omentectomy and Metabolic SyndromeCompletedNCT00923260
14Dynamic Position Change in Colonic Adenoma DetectionCompletedNCT01366079
15Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI DisordersCompletedNCT01099111
16Retroview Colonoscope for the Evaluation of Colon Mucosa StudyCompletedNCT02352233
17Investigate the Radical Extent of Lymphadenectomy of LAparoscopic Right Colectomy for Colon Cancer(RELARC).RecruitingNCT02619942
18Intracorporeal or Extracorporeal Anastomosis After Laparoscopic Right Colectomy.RecruitingNCT03045107
19Impact of Additional DJ (Duodenojejunostomy)-Pexy on Reduction in Delayed Gastric Emptying Following Pylorus-preserving Pancreaticoduodenectomy: A Prospective, Randomized Controlled TrialRecruitingNCT02635399
20A Study of Laparoscopic Right Hemicolectomy Using the Caudal-to-cranial ApproachRecruitingNCT02949440
21Feasibility and Effectiveness of Colonic IrrigationActive, not recruitingNCT02826967
22A Study Between Two Instrument Generations to Improve Adenoma Detection in Screening ColonoscopyActive, not recruitingNCT03137277
23Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC)Not yet recruitingNCT02942238

Search NIH Clinical Center for Transverse Colon Cancer

Genetic Tests for Transverse Colon Cancer

About this section

Anatomical Context for Transverse Colon Cancer

About this section

MalaCards organs/tissues related to Transverse Colon Cancer:

36
Colon, Liver, Pancreas, Lymph node, Bone, Bone marrow

Publications for Transverse Colon Cancer

About this section

Articles related to Transverse Colon Cancer:

(show all 42)
idTitleAuthorsYear
1
Delayed cecal perforation after successful colonic metal stenting in a patient with transverse colon cancer. (27059038)
2016
2
Short- and long-term outcomes of laparoscopic surgery vs open surgery for transverse colon cancer: a retrospective multicenter study. (27143915)
2016
3
Laparoscopic resection of transverse colon cancer at splenic flexure: technical aspects and results. (27015933)
2016
4
Perioperative and short-term oncological outcomes of single-port surgery for transverse colon cancer. (27699489)
2016
5
Pseudo-Meigs' syndrome secondary to metachronous ovarian metastases from transverse colon cancer. (27182170)
2016
6
Laparoscopic Complete Mesocolic Excision versus Open Complete Mesocolic Excision for Transverse Colon Cancer: Long-Term Survival Results of a Prospective Single Centre Non-Randomized Study. (26734758)
2016
7
Laparoscopic complete mesocolic excision via combined medial and cranial approaches for transverse colon cancer. (27566603)
2016
8
Bullous pemphigoid with IgG autoantibodies to BP180 C-terminal domain and desmocollin 3 associated with transverse colon cancer. (26693637)
2015
9
Robotic transverse colectomy for mid-transverse colon cancer: surgical techniques and oncologic outcomes. (26531113)
2015
10
Initial experience of robotic versus laparoscopic colectomy for transverse colon cancer: a matched case-control study. (26452727)
2015
11
Ten-millimeter advanced transverse colon cancer accompanied by a sessile serrated adenoma and/or polyp. (25892059)
2015
12
Comparison of long-term follow up of laparoscopic versus open colectomy for transverse colon cancer. (26130871)
2015
13
Outcome of Laparoscopic Versus Open Resection for Transverse Colon Cancer. (26197767)
2015
14
Transverse colon cancer occurring at a colostomy site 35 years after colostomy: a case report. (25943390)
2015
15
Laparoscopic Surgery for Transverse Colon Cancer: Short- and Long-Term Outcomes in Comparison with Conventional Open Surgery. (26583447)
2015
16
Hematochezia due to Caecal Angiodysplazia led to Diagnosis of a Transverse Colon Cancer in a Young Female Patient: Case Report and Literature Review. (26305206)
2015
17
Preoperative assessment of vascular anatomy by multidetector computed tomography before laparoscopic colectomy for transverse colon cancer: report of a case. (25692419)
2015
18
Metastatic mucinous adenocarcinoma of the distal common bile duct, from transverse colon cancer presenting as obstructive jaundice. (26379735)
2015
19
Laparoscopic colectomy for transverse colon cancer: comparative analysis of short- and long-term outcomes. (26629108)
2015
20
Laparoscopic versus open resection for transverse colon cancer. (25303924)
2014
21
Long-term outcomes of laparoscopic surgery for advanced transverse colon cancer. (24449001)
2014
22
Comparative study of oncologic outcomes for laparoscopic vs. open surgery in transverse colon cancer. (24761404)
2014
23
A Report of Disseminated Carcinomatosis of the Bone Marrow Originating from Transverse Colon Cancer Successfully Treated with Chemotherapy Using XELOX plus Bevacizumab. (25126072)
2014
24
Transverse colon cancer presenting as acute abdominal wall abscess. (24798363)
2014
25
Gastrocolic fistula secondary to transverse colon cancer. (24717990)
2014
26
Invasive adenocarcinoma arising from a mixed hyperplastic/adenomatous polyp and synchronous transverse colon cancer. (23984814)
2013
27
A long adult intussusception secondary to transverse colon cancer. (23801849)
2013
28
The transverse colon cancer with the reversed rotation of the midgut treated with single incision laparoscopic colectomy. (24426562)
2013
29
Short- and long-term results of laparoscopic surgery for transverse colon cancer. (23934542)
2013
30
Laparoscopic colectomy for transverse colon cancer in an automated peritoneal dialysis patient: A case report. (23706995)
2013
31
Laparoscopic resection of transverse colon cancer: long-term oncologic outcomes in 58 patients. (22690652)
2012
32
A new approach to laparoscopic lymph node excision in cases of transverse colon cancer. (22269292)
2012
33
Surgical resection of locally advanced primary transverse colon cancer--not a worse outcome in stage II tumor. (21279365)
2011
34
Curative resection of transverse colon cancer via minilaparotomy. (21675613)
2011
35
Short-term outcomes of laparoscopic colectomy for transverse colon cancer. (20224982)
2010
36
Left paraduodenal hernia incidentally diagnosed during operation for transverse colon cancer. (20453424)
2010
37
Hybrid hand-assisted colectomy for transverse colon cancer: a useful technique for non-expert laparoscopic surgeons. (19823906)
2009
38
A comparative study on the short-term clinicopathologic outcomes of laparoscopic surgery versus conventional open surgery for transverse colon cancer. (19263150)
2009
39
Surgical and pathological outcomes of laparoscopic surgery for transverse colon cancer. (18379794)
2008
40
Successful simultaneous operation of concomitant early gastric cancer, transverse colon cancer, and a common iliac artery aneurysm. (10483757)
1999
41
A case of transverse colon cancer secondarily involving the liver, duodenum, and pancreas. (8680119)
1996
42
Gastrocolic fistula originating from transverse colon cancer: report of a case and review of the Japanese literature. (7780232)
1994

Variations for Transverse Colon Cancer

About this section

Expression for genes affiliated with Transverse Colon Cancer

About this section
Search GEO for disease gene expression data for Transverse Colon Cancer.

Pathways for genes affiliated with Transverse Colon Cancer

About this section

GO Terms for genes affiliated with Transverse Colon Cancer

About this section

Cellular components related to Transverse Colon Cancer according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mismatch repair complexGO:003230010.8MSH2, PMS2
2MutLalpha complexGO:003238910.7MLH1, PMS2
3MutSalpha complexGO:003230110.7MSH2, MSH6
4plasma membraneGO:00058866.1CEACAM5, COL17A1, DSC2, DSC3, EPB41L5, GNAS

Biological processes related to Transverse Colon Cancer according to GeneCards Suite gene sharing:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1determination of adult lifespanGO:000834010.6MSH2, MSH6
2positive regulation of isotype switching to IgA isotypesGO:004829810.4MLH1, MSH2
3maintenance of DNA repeat elementsGO:004357010.4MSH2, MSH6
4positive regulation of isotype switching to IgG isotypesGO:004830410.4MLH1, MSH2
5negative regulation of DNA recombinationGO:004591010.4MSH2, MSH6
6positive regulation of helicase activityGO:005109610.3MSH2, MSH6
7intrinsic apoptotic signaling pathway in response to DNA damageGO:000863010.3MLH1, MSH2, MSH6
8isotype switchingGO:004519010.3MLH1, MSH2, MSH6
9response to isolation stressGO:003590010.3HRAS, KRAS
10epidermal growth factor receptor signaling pathwayGO:000717310.2HRAS, KRAS, PIK3C2A
11positive regulation of actin cytoskeleton reorganizationGO:200025110.1HCK, HRAS
12female pregnancyGO:000756510.1GNAS, KRAS, THBD
13somatic recombination of immunoglobulin genes involved in immune responseGO:000220410.0MLH1, MSH2
14mismatch repairGO:00062989.8MLH1, MSH2, MSH6, PMS2
15cornificationGO:00702689.6DSC2, DSC3, KRT20, KRT7
16keratinizationGO:00314249.5DSC2, DSC3, KRT20, KRT7
17somatic recombination of immunoglobulin gene segmentsGO:00164479.5MLH1, MSH2, MSH6
18somatic hypermutation of immunoglobulin genesGO:00164469.5MLH1, MSH2, MSH6, PMS2
19leukocyte migrationGO:00509009.4CEACAM5, HRAS, KRAS, THBD

Molecular functions related to Transverse Colon Cancer according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1MutSalpha complex bindingGO:003240710.5MLH1, PMS2
2four-way junction DNA bindingGO:000040010.4MSH2, MSH6
3MutLalpha complex bindingGO:003240510.4MSH2, MSH6
4oxidized purine DNA bindingGO:003235710.4MSH2, MSH6
5single guanine insertion bindingGO:003214210.4MSH2, MSH6
6single thymine insertion bindingGO:003214310.4MSH2, MSH6
7guanine/thymine mispair bindingGO:003213710.2MLH1, MSH2, MSH6
8ATPase activityGO:00168879.9MLH1, MSH2, MSH6, PMS2
9mismatched DNA bindingGO:00309839.9MLH1, MSH2, MSH6, PMS2
10single-stranded DNA bindingGO:00036979.7MLH1, MSH2, PMS2

Sources for Transverse Colon Cancer

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet